SCHEMBL9193954

SCHEMBL9193954

Nc1ccc(C(c2ccccc2F)n2ccnc2)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 14/20 0.50
▸ CYP11B1 P15538 2/20 0.50
▸ CYP11B2 P19099 2/20 0.50
▸ CYP17A1 P05093 2/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ NR1I2 O75469 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ABCB11 O95342 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PLA2G1B P04054 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ PGR P06401 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ IDO1 P14902 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MAOA P21397 1/20 0.38
▸ CNR1 P21554 1/20 0.38
▸ HTR2A P28223 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9191682 0.85 CYP19A1 (0.62) CYP19A1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL10477336 0.84 CYP19A1 (0.61) CYP19A1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL9235863 0.80 CYP19A1 (0.55) CYP19A1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL9190551 0.75 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL9193057 0.74 TDP1 (0.44) MEN1ALDH1A1HSP90AA1CYP3A4MAPT
SCHEMBL9194817 0.74 CYP17A1 (0.50) CYP19A1CYP11B1CYP11B2CYP17A1CYP3A4
SCHEMBL9198545 0.73 CYP17A1 (0.52) CYP19A1CYP17A1TSHRADRB2
SCHEMBL9192600 0.73 CYP17A1 (0.52) CYP19A1CYP17A1MEN1ALDH1A1CYP3A4
SCHEMBL9523782 0.72 CYP19A1 (0.60) CYP19A1CYP11B1CYP11B2CYP17A1MEN1
SCHEMBL11461900 0.71 CYP11B1 (0.48) CYP19A1CYP11B1CYP11B2CYP17A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0371564-B1 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA NV (BE) 1995-07-12 — — EP disclosed
US-5151421-A Compounds for inhibition of metabolism of retinoids, for treatment for proliferation of epithelial cells and keratin disorders JANSSEN PHARMACEUTICA N.V. (BE) 1992-09-29 — — US disclosed
US-5028606-A Retinoid metabolism inhibitors JANSSEN PHARMACEUTICA N.V. (BE) 1991-07-02 — — US disclosed
EP-0371564-A2 (1H-azol-1-ylmethyl)substituted quinoline, quinazoline or quinoxaline derivatives JANSSEN PHARMACEUTICA N.V. (BE) 1990-06-06 — — EP disclosed
Send feedback